Highlights Amneal Pharmaceuticals, Inc.

Equities

AMRX

US03168L1052

Real-time Estimate Cboe BZX Other stock markets 01:26:09 09/05/2024 am IST			5-day change	1st Jan Change
6.595 ^USD	+1.31%		+7.76%	+8.65%

06/05	Goldman Sachs Adjusts Amneal Pharmaceuticals Price Target to $8 From $6.25, Maintains Buy Rating	MT
03/05	Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Drugmaker Amneal agrees to $270 million U.S. opioid settlement	03/05	RE
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	03/05	MT
Amneal Pharmaceuticals Q1 Adjusted Earnings, Revenue Climb	03/05	MT
(AMRX) AMNEAL PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $0.53 - $0.63	03/05	MT
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Reports Q1 Revenue $659.2M, vs. Street Est of $619M	03/05	MT
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Posts Q1 EPS $0.14, vs. Street Est of $0.09	03/05	MT
North American Morning Briefing : Apple, Amgen -2-	03/05	DJ
Amneal Pharmaceuticals, Inc. Affirms Earnings Guidance for Full Year 2024	03/05	CI
Amneal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05	CI
Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	25/04	MT
Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray	24/04	DJ
Amneal Announces U.S. FDA Approval of Over-The-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose	24/04	CI
Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US	18/04	MT
Amneal Pharmaceuticals Announces Launch of Pemetrexed Injection, 100mg/10 Mg/10 Mg/50 Mg/Ll	18/04	CI
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says	12/04	MT
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds	12/04	MT
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision	09/04	RE
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals	08/04	MT
Amneal Pharmaceuticals Receives FDA Approval for Ear Infection Treatment	26/03	MT
Amneal Pharmaceuticals, Inc Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension	26/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Amneal Pharmaceuticals, Inc.

Equities

AMRX

US03168L1052

Highlights

Filters